Norstictic Acid

Norstictic Acid

SCHEMBL13287269

Cc1cc(O)c(C=O)c2c1C(=O)Oc1c(C)c(O)c3c(c1O2)C(O)OC3=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 1.00
KDM4E B2RXH2 5/20 1.00
MEN1 O00255 5/20 1.00
ALDH1A1 P00352 5/20 1.00
KMT2A Q03164 5/20 1.00
TDP1 Q9NUW8 5/20 1.00
HPGD P15428 4/20 1.00
CYP3A4 P08684 4/20 1.00
PHPT1 Q9NRX4 2/20 1.00
ALOX12 P18054 2/20 1.00
CASP1 P29466 1/20 1.00
MED25 Q71SY5 1/20 1.00
SLCO1B3 Q9NPD5 1/20 1.00
SLCO1B1 Q9Y6L6 1/20 1.00
THRB P10828 3/20 0.77
RECQL P46063 3/20 0.77
POLB P06746 2/20 0.77
L3MBTL1 Q9Y468 2/20 0.77
USP2 O75604 2/20 0.77
GAA P10253 1/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Norstictic Acid SCHEMBL29369714 1.00 MAPT (1.00) MAPTKDM4EMEN1ALDH1A1KMT2A
Stictic Acid SCHEMBL29394416 0.87 KDM4E (1.00) MAPTKDM4EMEN1ALDH1A1KMT2A
Stictic Acid SCHEMBL13495711 0.87 KDM4E (1.00) MAPTKDM4EMEN1ALDH1A1KMT2A
Slazinic Acid SCHEMBL3801772 0.87 MAPT (1.00) MAPTKDM4EMEN1ALDH1A1KMT2A
SCHEMBL15581642 0.87 MAPT (0.85) MAPTKDM4EMEN1ALDH1A1KMT2A
SCHEMBL17694852 0.86 KDM4E (0.87) MAPTKDM4EMEN1ALDH1A1KMT2A
SCHEMBL30509240 0.82 KDM4E (0.76) MAPTKDM4EMEN1ALDH1A1KMT2A
SCHEMBL17049615 0.81 MEN1 (0.68) MAPTKDM4EMEN1ALDH1A1KMT2A
SCHEMBL15581643 0.80 KDM4E (0.66) MAPTKDM4EMEN1ALDH1A1KMT2A
SCHEMBL15125097 0.80 KDM4E (0.71) MAPTKDM4EMEN1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9527878-B2 Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2016-12-27 US disclosed
US-9527878-B2 Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2016-12-27 US disclosed
US-20160009748-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITORS AND METHODS OF USE THEREOF TO MODULATE LIPID METABOLISM THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2016-01-14 US disclosed
US-20160009748-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITORS AND METHODS OF USE THEREOF TO MODULATE LIPID METABOLISM THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2016-01-14 US disclosed
US-9120744-B2 Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2015-09-01 US disclosed
US-20100137194-A1 Plasminogen Activator Inhibitor-1 Inhibitors and Methods of Use Thereof to Modulate Lipid Metabolism THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2010-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137194-A1 Plasminogen Activator Inhibitor-1 Inhibitors and Methods of Use Thereof to Modulate Lipid Metabolism SERPINE1, PLAT, SERPINB1 MAPT 3350/4885KDM4E 3907/4885MEN1 1398/4885
US-20160009748-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITORS AND METHODS OF USE THEREOF TO MODULATE LIPID METABOLISM SERPINE1, PLAT, SERPINB1 MAPT 3350/4885KDM4E 3907/4885MEN1 1398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.